The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Valone Frank H Md since 2015.
The trader's CIK number is 1182657.
At the time of the last reporting, Valone Frank H Md was the Chief Medical Officer of Fibrogen Inc. (stock ticker symbol FGEN).
Also see all insider trading activities at Fibrogen Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2016 | FGEN | 0 | $0 | 21,500 | $412,025 | 31,500 | $108,194 |
| 2015 | FGEN | 0 | $0 | 51,000 | $1,171,492 | 61,000 | $154,350 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2016-04-01 | FGEN | Sale | 10,750 | 21.29 | 228,835 |
| 2016-04-01 | FGEN | Option Ex | 10,750 | 3.92 | 42,193 |
| 2016-03-01 | FGEN | Option Ex | 10,750 | 3.44 | 37,001 |
| 2016-03-01 | FGEN | Sale | 10,750 | 17.04 | 183,190 |
| 2016-01-22 | FGEN | Option Ex | 10,000 | 2.90 | 29,000 |
| 2015-11-13 | FGEN | Option Ex | 10,000 | 2.90 | 29,000 |
| 2015-11-02 | FGEN | Option Ex | 10,000 | 2.90 | 29,000 |
| 2015-11-02 | FGEN | Sale | 10,000 | 23.45 | 234,500 |
| 2015-10-19 | FGEN | Option Ex | 10,000 | 2.35 | 23,500 |
| 2015-10-19 | FGEN | Sale | 10,000 | 23.00 | 230,000 |
| 2015-10-01 | FGEN | Option Ex | 10,000 | 2.35 | 23,500 |
| 2015-10-01 | FGEN | Sale | 10,000 | 21.38 | 213,780 |
| 2015-09-01 | FGEN | Option Ex | 10,000 | 2.35 | 23,500 |
| 2015-09-01 | FGEN | Sale | 10,000 | 23.58 | 235,780 |
| 2015-08-03 | FGEN | Option Ex | 10,000 | 2.35 | 23,500 |
| 2015-08-03 | FGEN | Sale | 10,000 | 23.37 | 233,730 |
| 2015-07-20 | FGEN | Option Ex | 1,000 | 2.35 | 2,350 |
| 2015-07-20 | FGEN | Sale | 1,000 | 23.70 | 23,702 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Valone Frank H Md (Chief Medical Officer of Fibrogen Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.